CRMD - CorMedix Inc.
NEXT EARNINGS:
Mar 24, 2026
(in 27 days)
EPS Est: $0.86
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$14.00
DETAILS
HIGH:
$16.00
LOW:
$13.00
MEDIAN:
$13.00
CONSENSUS:
$14.00
UPSIDE:
98.02%
Market Cap:
557.04M
Volume:
944,756
Avg Volume:
2,969,106
52 Week Range:
5.6-17.43
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.30
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
64
IPO Date:
2010-05-13
EPS (TTM):
-0.30
P/E Ratio:
-26.60
Revenue (TTM):
43.47M
Total Assets:
118.85M
Total Debt:
517,013
Cash & Equiv:
40.65M
Rev Growth (5Y):
173.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-22.7%
Debt/Equity:
0.01
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-12 | $0.57 | $0.48 | +18.7% | $104.3M | $127.0M | -17.9% |
| 2025-08-07 | $0.28 | $0.20 | +40.0% | $39.7M | $42.5M | -6.4% |
| 2025-05-06 | $0.30 | $0.25 | +20.0% | $39.1M | $29.9M | +30.8% |
| 2025-03-25 | $0.22 | $0.17 | +29.4% | $31.2M | $31.3M | -0.2% |
| 2024-10-30 | $-0.05 | $-0.10 | +50.0% | $11.5M | $19.8M | -42.1% |
| 2024-08-14 | $-0.25 | $-0.26 | +3.8% | $806119 | $1.7M | -51.7% |
| 2024-05-09 | $-0.25 | $-0.27 | +7.4% | — | — | — |
| 2024-03-12 | $-0.26 | $-0.21 | -23.8% | $304110 | $-250000 | +221.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.47M | 0 | 65,408 | 190,936 | 239,231 | 283,266 | 429,797 | 329,327 | 224,105 | 210,130 | 189,274 | 2,000 |
| Net Income | (17.93M) | (46.34M) | (29.70M) | (28.21M) | (22.03M) | (16.43M) | (26.83M) | (33.01M) | (24.64M) | (18.19M) | (20.45M) | (9.13M) |
| EPS | -0.30 | -0.91 | -0.74 | -0.75 | -0.77 | -0.68 | -1.51 | -2.99 | -3.25 | -2.90 | -4.77 | -3.30 |
| Total Assets | 118.85M | 82.06M | 62.04M | 68.95M | 49.31M | 29.48M | 18.83M | 13.45M | 21.91M | 37.10M | 5.10M | 2.97M |
| Total Debt | 517,013 | 667,632 | 802,433 | 923,801 | 1.03M | 4,689 | 6.13M | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 40.65M | 43.64M | 43.37M | 53.32M | 41.91M | 16.53M | 17.62M | 10.38M | 8.06M | 11.82M | 4.34M | 2.37M |
| Operating Cash Flow | (50.61M) | (38.41M) | (24.36M) | (21.16M) | (21.97M) | (15.05M) | (23.70M) | (28.59M) | (22.27M) | (12.53M) | (6.32M) | (3.62M) |
| Free Cash Flow | (50.73M) | (38.74M) | (24.58M) | (22.58M) | (22.08M) | (15.09M) | (23.75M) | (28.74M) | (22.32M) | (12.54M) | (6.35M) | (3.65M) |
| FCF per Share | -0.86 | -0.76 | -0.61 | -0.60 | -0.77 | -0.62 | -1.33 | -2.61 | -2.94 | -2.00 | -1.48 | -1.32 |
| Book Value | 84.66M | 70.14M | 55.06M | 62.80M | 44.22M | (195.42M) | (178.99M) | (152.17M) | 17.81M | 34.01M | 3.63M | (4.02M) |
| Cash & ST Investments | 51.69M | 76.03M | 59.02M | 65.47M | 46.35M | 28.51M | 17.62M | 11.98M | 20.17M | 35.39M | 4.34M | 2.37M |
| ROC Equity | -0.21 | -0.66 | -0.54 | -0.45 | -0.50 | N/A | N/A | N/A | -1.38 | -0.53 | -5.63 | N/A |